Content and data provided by various third parties and Fidelity - Terms of Use

ETF / ETP Details

RELATED RESOURCES

NEW — Intraday Technical Analysis now available from TRADING Central.
Visit News, Commentary & Events.

Snapshot: FHLC

FIDELITY MSCI HEALTH CARE INDEXFidelity

35.00down-0.18 (-0.51%)

 as of 4:00:00pm ET 02/27/2015
Bid/Size 0.00/0
Ask/Size 35.30/0
Open 35.23
High 35.23
Low 34.9883
Previous Close
AS OF 02/27/2015		 35.00
Price Performance (Last 52 Wk)
as of 02/27/2015		 +21.91%
Volume 0
Volume (90-Day Average) 192,119
Indicative Intraday Value Log in
NAV (Previous Day)
AS OF 02/27/2015 		34.985024
Bid/Ask Midpoint (Previous Day)
AS OF 02/27/2015		 34.99
Bid/Ask Spread (1 Month Average)
as of 01/30/2015		 0.07%
Premium / Discount (Previous Day)
as of 02/27/2015		 0.04%
Premium / Discount (1 Month Rolling Average)
as of 02/27/2015		 0.03%
Tracking Error 0.06
Options No
Detailed Quote
Reset Chart
Advanced Chart

Note: You can save only one view at the time. Saving this view will overwrite your previously saved view.

Please use the Advanced Chart if you want to have more than one view.

Cancel 
Save View
Your view has been saved
Failed
Your view hasn't been saved
TODAY 2D 5D 10D 1M 3M 6M YTD 1Y 3Y 5Y 10Y
DELAYED DATA AS OF
Text Note
Cancel
Chart Settings
Show/Hide


Cancel

Please note you can display only one indicator at a time in this view. Please use Advanced Chart if you want to display more than one.

Cancel
Attention

Please note you can display only one indicator at a time in this view. Please use Advanced Chart if you want to display more than one.

Don't show again

ETP Type

ETF

Asset Class

Equity

Geography Objective

US

Capitalization / Style Objective

Broad/Multi Cap / Core or Blend

Sector Objective

Healthcare

Net Assets
AS OF 01/31/2015

$454.5M

Net Expense Ratio

0.12%

Sponsor

Fidelity Management & Research

Inception Date

10/21/2013

Investment Philosophy

Passively Managed

Benchmark Index

MSCI USA IMI Health Care Index

Index Composition

Cap-Weighted

Legal Structure

Open-End Investment Company

Basket Total Holdings

319

Objective

Seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care Index. Investing at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care Index, which represents the performance of the health care sector in the U.S. equity market. Using a representative sampling indexing strategy to manage the fund. “Representative sampling" is an indexing strategy that involves investing in a representative sample of securities that collectively has an investment profile similar to the index. The securities selected are expected to have, in the aggregate, investment characteristics (based on factors such as market capitalization and industry weightings), fundamental characteristics (such as return variability and yield) and liquidity measures similar to those of the index. The fund may or may not hold all of the securities in the MSCI USA IMI Health Care Index.

Learn More

News, Commentary & Events

Log in for more news
Error

Sorry : There are currently no news stories available for this symbol.

  • Sector Detector: Sector rankings stay neutral with few bullish catalysts on horizon

    BY Scott Martindale, Sabrient - 02/17/2015

    Stocks are hitting new highs across the board, even though earnings reports have been somewhat disappointing. Actually, to be more precise, Q4 results have been pretty good, but it is forward guidance that has been cautious and/or cloudy as sales into overseas markets are expected to suffer due to strength in the US dollar. Evidently, U.S. equities remain a relative safe haven for cautious but hungry global investors who have cheap money in their clutches, thanks to global liquidity and currency wars that allow them to benefit on the exchange with a strengthening dollar. Although the SPY chart certainly looks bullish, I still think it is likely that we will get a longer period of consolidation, and perhaps some retesting of support levels, before there is enough conviction to go much higher. Overall, this week's fundamentals-based Outlook rankings look even more neutral in my view -- and perhaps even a bit defensive -- as market sentiment continues to grow more cautionary. Nevertheless, our trend-following sector rotation model retains a bullish bias and suggests holding Technology, Financial, and Healthcare sectors. Also discussed are some alternative highly-ranked ETFs and individual stock ideas from within the top-ranked sectors, and what the model suggests if you prefer a neutral or defensive outlook.

  • Sector Detector: Neutral indicators and mixed reports, but sector rotation model still bullish

    BY Scott Martindale, Sabrient - 02/09/2015

    Volatility continues as the parade of mixed earnings and economic reports marches along amidst a backdrop of global unrest and economic uncertainties. This has led to a neutral near-term outlook for both the technical picture and fundamentals-based sector rankings. Nevertheless, the longer-term trends appear to favor further flattening of the yield curve and continued strength in the dollar, gold, volatility, and equities. Overall, this week's fundamentals-based Outlook rankings have taken a neutral turn in my view, as market sentiment continues to grow more cautionary. Nevertheless, our sector rotation model has moved to a bullish bias and suggests holding Technology, Financial, and Energy sectors. Also discussed are some alternative highly-ranked ETFs and individual stock ideas from within the top-ranked sectors, and what the model suggests if you prefer a neutral or defensive outlook.

More News, Commentary & Events

Analyst Opinions

Analyst Ratings

LAST CHANGE
Firm Name As of Date Action Rating Report
S&P Capital IQ 09/30/2014 Upgrade Log in for rating & report
Ned Davis Research Group 01/07/2015 Upgrade Log in for rating & report
XTF Inc. 01/30/2015 Downgrade 9.70000 out of 10 XTF Inc. PDF Report
More Analyst Opinions

Key Statistics

Price / Earnings (Trailing Twelve Months) 25.44
Price / Book 4.13
Price / Sales 2.01
Price / Cash Flow 16.82
30-day SEC Yield
AS OF 02/20/2015		1.13%
Distribution Yield (TTM)
AS OF 01/31/2015		 1.01
See all Key Stats

Compare

FHLC
FIDELITY MSCI HEALTH CARE INDEX		 Asset Class Median
Volume (10-Day Avg)
AS OF 02/26/2015		 155.8K 23.4M
1 Week Market Total Return
AS OF 02/26/2015		 +1.79% +0.65%
1 Month Market Total Return
AS OF 02/26/2015		 +2.27% +3.12%
1 Year Market Total Return
AS OF 02/26/2015		 +24.38% +7.69%
3 Year Annualized Market Total Return
AS OF 02/26/2015		 -- +11.98%
Beta (1 Year Month-End)
AS OF 01/31/2015		 0.84 1.06
Annual Turnover Ratio
AS OF --		 -- 18.00%
Net Expense Ratio
AS OF 11/29/2014		 0.12% 0.58%
Compare to Other ETFs

Performance

Growth of Hypothetical $10,000 * AS OF 01/31/2015

Cumulative Total Returns AS OF 02/26/2015
NAV Return Market Return S&P 500 Index
YTD +6.95% +6.93% +2.88%
4 Weeks +2.31% +2.27% +2.88%
13 Weeks +6.64% +6.66% +2.36%
26 Weeks +15.93% +15.90% +6.66%
Quarter-End Average Annual Total Returns AS OF 12/31/2014
NAV Return Market Return
1 Year +25.22% +25.06%
3 Year -- --
5 Year -- --
10 Year -- --
Life +27.29% +26.43%
Life as of inception date: 10/21/2013       Gross Expense Ratio: 0.12%

The performance data featured represents past performance, which is no guarantee of future results. Investment return and principal value of an investment will fluctuate; therefore, you may have a gain or loss when you sell your shares. Current performance may be higher or lower than the performance data quoted.

More about Performance & Risk

Portfolio Composition

Top 10 Basket Holdings AS OF 02/27/2015

View all Basket Holdings
JNJ Johnson & Johnson 8.69%
PFE Pfizer Inc 6.54%
MRK Merck & Co Inc 5.08%
GILD Gilead Sciences Inc 4.71%
AMGN Amgen Inc 3.61%
UNH UnitedHealth Group Inc 3.32%
MDT Medtronic PLC 3.30%
BMY Bristol-Myers Squibb Co 3.04%
CELG Celgene Corp 2.93%
BIIB Biogen Idec Inc 2.90%
†Part or all of this cash position may represent cash-in-lieu of marketable securities and not actual cash.Click here for more information.More about Portfolio Composition

StyleMap®

as of 02/27/2015 More information
Value Blend Growth
Large StyleMap: Large Growth
Mid
Small
Current HistoricalCurrent Fund Assets Coverage: 100%
Data provided by . More about Portfolio Composition
Free commission offer applies to online purchases of Fidelity ETFs and select iShares ETFs in a Fidelity brokerage account. Fidelity accounts may require minimum balances. The sale of ETFs is subject to an activity assessment fee (of between $0.01 to $0.03 per $1,000 of principal). iShares ETFs and Fidelity ETFs are subject to a short-term trading fee by Fidelity if held less than 30 days. *The chart illustrates the NAV performance of a hypothetical $10,000 investment made in the fund on 12/31/1999 or on commencement of operations (whichever is later). Figures include reinvestment of capital gains and dividends, but do not reflect the effect of any applicable sales charges or redemption fees, which would lower these figures. This chart is not intended to imply any future performance of the fund.

**The Overall Morningstar RatingTM for a fund is derived from a weighted average of the performance figures associated with its three-, five-, and ten-year (if applicable) Morningstar Rating metrics. For each fund with at least a three-year history, Morningstar calculates a Morningstar Rating based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a funds monthly performance (including the effects of sales charges, loads and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund within this scale and rated separately, which may cause slight variations in the distribution percentages.)

The performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. Click on the "Performance & Risk" link to view quarter-end performance. Average annual total returns are historical and include change in share value and reinvestment of dividends and capital gains, if any. Cumulative total returns are reported as of the period indicated. Life of fund figures are reported as of the commencement date to the period indicated. Since ETFs are bought and sold at prices set by the market - which can result in a premium or discount to NAV- the returns calculated using market price (market return) can differ from those calculated using NAV (NAV return).

Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive, long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Additional information about the sources, amounts, and terms of compensation is described in the ETFs prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.

© 1998－2015 FMR LLC.

All rights reserved.